The effects of intensive glycaemic control on body composition in patients with type 2 diabetes

被引:25
作者
Bagg, W
Plank, LD
Gamble, G
Drury, PL
Sharpe, N
Braatvedt, GD
机构
[1] Univ Auckland, Dept Med, Auckland 1, New Zealand
[2] Univ Auckland, Dept Surg, Auckland 1, New Zealand
[3] Auckland Diabet Ctr, Auckland, New Zealand
关键词
intensive glycaemic control; body weight; blood pressure; serum lipid concentrations;
D O I
10.1046/j.1463-1326.2001.00153.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To examine the effects of improved glycaemic control over 20 weeks on the type and distribution of weight change in patients with type 2 diabetes who at baseline have poor glycaemic control. Methods Forty-three patients with type 2 diabetes and HbA(1c)>8.9% were randomised to either intensive glycaemic control (IC) n=21 or usual glycaemic control (UC) n=22 for 20 weeks. Dual energy X-ray absorptiometry was used to assess the type and distribution of weight change during the study. Results After 20 weeks HbA(1c) was significantly lower in patients randomised to IC than UC (HbA(1c) IC 8.02 +/-0.25% vs. UC 10.23 +/-0.23%, p<0.0001), In the IC group weight increased by 3.2<plus/minus>0.8 kg after 20 weeks (fat-free mass increased by 1.8 +/-0.3 kg) compared to 0.02 +/-0.70 kg in UC (p=0.003). The gain in total body fat mass comprised trunk fat mass (IC 0.94 +/-0.5 kg vs. UC 0.04 +/-0.4 kg, p=0.18) and peripheral fat mass (total body fat-trunk fat) (IC 0.71 +/-0.32 kg vs. UC -0.21 +/-0.28 kg, p=0.04). Blood pressure and serum lipid concentrations did not change over time in either group. Conclusions Intensive glycaemic control was associated with weight gain which was distributed in similar proportions between the central and peripheral regions and consisted of similar proportions of fat and fat-free mass. Blood pressure and serum lipid concentrations were not adversely affected.
引用
收藏
页码:410 / 416
页数:7
相关论文
共 20 条
  • [1] BAGG W, 2001, IN PRESS INT MED J
  • [2] Cull C, 1999, DIABETOLOGIA, V42, pA18
  • [3] MEASURING THE ALBUMIN EXCRETION RATE - AGREEMENT BETWEEN METHODS AND BIOLOGICAL VARIABILITY
    CUNDY, TF
    NIXON, D
    BERKAHN, L
    BAKER, J
    [J]. DIABETIC MEDICINE, 1992, 9 (02) : 138 - 143
  • [4] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [5] THE CASE FOR USING WAIST TO HIP RATIO MEASUREMENTS IN ROUTINE MEDICAL CHECKS
    EGGER, G
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1992, 156 (04) : 280 - 285
  • [6] Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins -: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus
    Emanuele, N
    Azad, N
    Abraira, C
    Henderson, W
    Colwell, J
    Levin, S
    Nuttall, F
    Comstock, J
    Sawin, C
    Silbert, C
    Marcovina, S
    Lee, HS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (22) : 2485 - 2490
  • [7] Forbes GB, 2000, ANN NY ACAD SCI, V904, P359
  • [8] INTENSIVE CONVENTIONAL INSULIN THERAPY FOR TYPE-II DIABETES - METABOLIC EFFECTS DURING A 6-MONTH OUTPATIENT TRIAL
    HENRY, RR
    GUMBINER, B
    DITZLER, T
    WALLACE, P
    LYON, R
    GLAUBER, HS
    [J]. DIABETES CARE, 1993, 16 (01) : 21 - 31
  • [9] DIABETES INCIDENCE IN PIMA-INDIANS - CONTRIBUTIONS OF OBESITY AND PARENTAL DIABETES
    KNOWLER, WC
    PETTITT, DJ
    SAVAGE, PJ
    BENNETT, PH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 113 (02) : 144 - 156
  • [10] Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus
    Mäkimattila, S
    Nikkilä, K
    Yki-Järvinen, H
    [J]. DIABETOLOGIA, 1999, 42 (04) : 406 - 412